TABLE 6.
Effect of treatment with CDV on mortality of SCID mice inoculated i.p. with CV-BR or VV-WR
| Virus | Treatment | Mortality rate (%) | P | MDD | P |
|---|---|---|---|---|---|
| CV-BR | Placebo-saline | 15/15 (100) | 8.3 | ||
| CDV | |||||
| +48 h | |||||
| 20 mg/kg | 15/15 (100) | NSa | 17.3 | <0.001 | |
| 6.7 mg/kg | 15/15 (100) | NS | 10.7 | <0.05 | |
| 2.2 mg/kg | 15/15 (100) | NS | 8.0 | NS | |
| +72 h | |||||
| 20 mg/kg | 14/15 (93) | NS | 11.9 | <0.01 | |
| 6.7 mg/kg | 15/15 (100) | NS | 10.0 | NS | |
| 2.2 mg/kg | 15/15 (100) | NS | 7.7 | NS | |
| VV-WR | Placebo-saline | 10/10 (100) | 12.7 | ||
| CDV | |||||
| +72 h | |||||
| 20 mg/kg | 10/10 (100) | NS | 22.7 | <0.001 | |
| 6.7 mg/kg | 10/10 (100) | NS | 19.9 | <0.001 | |
| 2.2 mg/kg | 10/10 (100) | NS | 18.3 | <0.001 | |
| +96 h | |||||
| 20 mg/kg | 10/10 (100) | NS | 19.6 | 0.001 | |
| 6.7 mg/kg | 10/10 (100) | NS | 17.9 | <0.001 | |
| 2.2 mg/kg | 10/10 (100) | NS | 15.7 | <0.05 |
NS, result not significant compared to that of the placebo control.